At a glance: Wyeth to shake up contraceptive market
What’s happening? Wyeth Pharmaceuticals is looking to launch an oral contraceptive, called Lybrel, which combines the chemicals levonorgestrel and ethinyl estradiol.
Sign in to continue
Need to activate your subscription?
Domain/Group Subscriptions
Click here >>
Individual Subscriptions
Click here >>
Need to activate your Subscription
Company Wide Subscriptions
Click here >>
UK Individual Subscribers
Click here >>